data_2n1b_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n1b _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.234 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.11 149.62 87.37 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 174.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 0.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 0.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.674 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.535 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.908 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 104' ' ' TRP . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 0.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 0.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 0.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 0.0 111.004 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.493 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.493 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 0.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 174.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 0.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 0.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.921 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 0.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 0.0 110.329 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.568 -173.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.503 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 0.0 110.17 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 0.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.7 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.479 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 0.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 0.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 0.0 111.19 -173.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 0.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.035 -174.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.178 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.535 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 0.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.015 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 82' ' ' GLN . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 0.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.416 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 0.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.601 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.44 174.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.228 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 0.0 110.402 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.933 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 0.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.135 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.436 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 0.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.917 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 0.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 0.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.601 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 0.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.013 175.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.085 -176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 0.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.501 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 0.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 0.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 0.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.978 -176.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 0.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 0.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 0.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.616 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 110.314 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.391 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 0.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.956 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 0.0 110.67 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 0.0 112.166 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.411 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.463 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 0.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 0.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 173.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.18 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 0.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 0.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 0.0 113.115 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 0.0 112.339 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 0.0 110.71 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 0.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.164 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 0.0 109.957 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 0.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 0.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 0.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 0.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.319 0 N-CA-C 111.089 -0.804 . . . . 100.0 111.089 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -72.14 149.62 92.01 Favored Pre-proline 0 C--O 1.233 0.211 0 C-N-CA 128.209 2.603 . . . . 100.0 109.912 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.535 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 104' ' ' TRP . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.493 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.493 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.479 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.535 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 82' ' ' GLN . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.416 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.601 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.436 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.601 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.501 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.616 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.411 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.463 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.56 0 N-CA-C 115.127 0.811 . . . . 100.0 115.127 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -68.54 149.62 97.93 Favored Pre-proline 0 C--O 1.233 0.211 0 C-N-CA 126.143 1.777 . . . . 100.0 109.912 -176.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.535 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 104' ' ' TRP . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.493 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.493 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.479 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.535 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 82' ' ' GLN . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.416 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.601 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.436 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.601 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.501 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.616 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.411 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.463 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.253 0 CA-C-O 121.869 0.705 . . . . 100.0 113.412 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.29 149.62 86.94 Favored Pre-proline 0 C--N 1.331 -0.224 0 C-N-CA 131.329 3.852 . . . . 100.0 109.912 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.535 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 104' ' ' TRP . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.493 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.493 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.479 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.535 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 82' ' ' GLN . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.416 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.601 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.436 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.601 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.501 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.616 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.411 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.463 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.562 0 N-CA-C 106.709 -2.556 . . . . 100.0 106.709 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -83.63 149.62 57.72 Favored Pre-proline 0 C--N 1.351 0.639 0 C-N-CA 123.873 0.869 . . . . 100.0 109.912 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.535 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 104' ' ' TRP . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.493 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.493 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.479 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.535 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 82' ' ' GLN . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.416 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.601 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.436 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.601 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.501 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.616 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.411 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.463 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.936 0 N-CA-C 105.6 -3.0 . . . . 100.0 105.6 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.598 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 68.7 mm-40 -85.62 177.16 3.05 Favored Pre-proline 0 N--CA 1.437 -1.118 0 C-N-CA 130.113 3.365 . . . . 100.0 105.899 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.598 ' HD2' ' HB3' ' A' ' 6' ' ' GLU . 40.2 Cg_endo -56.77 153.1 38.55 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 123.173 2.582 . . . . 100.0 110.041 177.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.535 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 104' ' ' TRP . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.493 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.493 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.479 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.535 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 82' ' ' GLN . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.416 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.601 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.436 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.601 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.501 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.616 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.411 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.463 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.736 0 N-CA-C 113.735 0.254 . . . . 100.0 113.735 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -71.45 149.62 93.74 Favored Pre-proline 0 C--N 1.346 0.428 0 C-N-CA 125.421 1.488 . . . . 100.0 109.912 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.535 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 104' ' ' TRP . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.493 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.493 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.479 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.535 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 82' ' ' GLN . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.416 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.601 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.436 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.601 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.501 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.616 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.411 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.463 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.363 0 CA-C-O 122.491 1.05 . . . . 100.0 111.534 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -68.9 149.62 97.82 Favored Pre-proline 0 C--O 1.233 0.211 0 C-N-CA 130.51 3.524 . . . . 100.0 109.912 176.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.535 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 104' ' ' TRP . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.493 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.493 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.479 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.535 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 82' ' ' GLN . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.416 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.601 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.436 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.601 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.501 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.616 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.411 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.463 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.223 0 N-CA-C 104.324 -3.51 . . . . 100.0 104.324 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.64 149.62 96.85 Favored Pre-proline 0 C--N 1.355 0.82 0 C-N-CA 123.243 0.617 . . . . 100.0 109.912 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.535 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 104' ' ' TRP . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.493 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.493 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.479 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.535 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 82' ' ' GLN . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.416 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.601 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.436 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.601 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.501 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.616 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.411 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.463 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.365 0 N-CA-C 105.881 -2.888 . . . . 100.0 105.881 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -75.01 149.62 85.32 Favored Pre-proline 0 C--N 1.357 0.906 0 CA-C-N 117.62 0.71 . . . . 100.0 109.912 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.535 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 104' ' ' TRP . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.493 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.493 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.479 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.535 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 82' ' ' GLN . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.416 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.601 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.436 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.601 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.501 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.616 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.411 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.463 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.7 tpp . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.91 98.6 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.378 -0.231 . . . . 0.0 110.378 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.39 150.9 45.78 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 175.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -118.26 153.76 33.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.673 0.273 . . . . 0.0 111.14 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.45 -0.17 77.26 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -172.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.11 149.62 87.37 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 174.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 0.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 0.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.674 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.535 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.908 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 104' ' ' TRP . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 0.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 0.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 0.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 0.0 111.004 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.493 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.493 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 0.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 174.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 0.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 0.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.921 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 0.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 0.0 110.329 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.568 -173.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.503 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 0.0 110.17 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 0.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.7 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.479 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 0.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 0.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 0.0 111.19 -173.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 0.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.035 -174.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.178 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.535 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 0.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.015 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 82' ' ' GLN . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 0.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.416 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 0.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.601 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.44 174.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.228 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 0.0 110.402 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.933 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 0.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.135 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.436 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 0.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.917 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 0.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 0.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.601 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 0.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.013 175.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.085 -176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 0.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.501 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 0.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 0.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 0.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.978 -176.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 0.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 0.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 0.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.616 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 110.314 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.391 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 0.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.956 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 0.0 110.67 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 0.0 112.166 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.411 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.463 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 0.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 0.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 173.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.18 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 0.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 0.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 0.0 113.115 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 0.0 112.339 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 0.0 110.71 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 0.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.164 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 0.0 109.957 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 0.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 0.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 0.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 0.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mmt . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 113.671 0.989 . . . . 100.0 113.671 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.17 143.55 52.24 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 109.281 -0.637 . . . . 100.0 109.281 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.5 81.21 5.96 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-O 121.705 0.765 . . . . 100.0 109.003 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -121.27 84.46 2.24 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.072 0.949 . . . . 100.0 109.832 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.37 -28.42 9.01 Favored Glycine 0 C--N 1.355 1.637 0 N-CA-C 111.089 -0.804 . . . . 100.0 111.089 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -72.14 149.62 92.01 Favored Pre-proline 0 C--O 1.233 0.211 0 C-N-CA 128.209 2.603 . . . . 100.0 109.912 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.535 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 104' ' ' TRP . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.493 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.493 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.479 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.535 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 82' ' ' GLN . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.416 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.601 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.436 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.601 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.501 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.616 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.411 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.463 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 ttt . . . . . 0 CA--C 1.484 -1.589 0 N-CA-C 107.156 -1.424 . . . . 100.0 107.156 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.11 80.21 1.68 Allowed 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 109.057 -0.72 . . . . 100.0 109.057 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.48 ' HB2' ' HD2' ' A' ' 58' ' ' PRO . . . -96.72 -10.06 27.66 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.974 -1.121 . . . . 100.0 107.974 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -97.92 110.96 23.43 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 105.102 -2.185 . . . . 100.0 105.102 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.98 -70.05 2.96 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 114.423 -1.262 . . . . 100.0 115.127 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -68.54 149.62 97.93 Favored Pre-proline 0 C--O 1.233 0.211 0 C-N-CA 126.143 1.777 . . . . 100.0 109.912 -176.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.535 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 104' ' ' TRP . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.493 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.493 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 3' ' ' ALA . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.479 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.535 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 82' ' ' GLN . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.416 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.601 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.436 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.601 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.501 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.616 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.411 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.463 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.406 ' HB2' HG21 ' A' ' 9' ' ' VAL . 8.3 mtm . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 121.175 0.512 . . . . 100.0 111.206 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.27 -4.72 38.3 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 109.116 -0.698 . . . . 100.0 109.116 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -95.29 8.24 43.73 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 123.892 0.877 . . . . 100.0 109.864 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -97.07 -7.93 31.57 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 108.35 -0.982 . . . . 100.0 108.35 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.91 -12.47 45.54 Favored Glycine 0 C--N 1.365 2.146 0 CA-C-N 119.655 1.116 . . . . 100.0 113.412 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.29 149.62 86.94 Favored Pre-proline 0 C--N 1.331 -0.224 0 C-N-CA 131.329 3.852 . . . . 100.0 109.912 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.406 HG21 ' HB2' ' A' ' 1' ' ' MET . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.535 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 104' ' ' TRP . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.493 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.493 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.479 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.535 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 82' ' ' GLN . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.416 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.601 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.436 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.601 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.501 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.616 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.411 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.463 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.467 ' H ' ' HB3' ' A' ' 56' ' ' ARG . 3.7 mtm . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 121.869 0.842 . . . . 100.0 111.644 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.421 ' CB ' ' HA ' ' A' ' 8' ' ' GLN . . . -61.64 139.84 58.23 Favored 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 125.305 1.442 . . . . 100.0 111.681 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.15 21.91 12.71 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 114.646 1.35 . . . . 100.0 114.646 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -108.06 14.26 25.33 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 106.514 -1.661 . . . . 100.0 106.514 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.48 -40.53 1.58 Allowed Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 106.709 -2.556 . . . . 100.0 106.709 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -83.63 149.62 57.72 Favored Pre-proline 0 C--N 1.351 0.639 0 C-N-CA 123.873 0.869 . . . . 100.0 109.912 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.421 ' HA ' ' CB ' ' A' ' 2' ' ' ALA . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.535 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 104' ' ' TRP . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.493 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.493 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.467 ' HB3' ' H ' ' A' ' 1' ' ' MET . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.479 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.535 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 82' ' ' GLN . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.416 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.601 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.436 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.601 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.501 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.616 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.411 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.463 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mtt . . . . . 0 CA--C 1.498 -1.045 0 N-CA-C 105.492 -2.04 . . . . 100.0 105.492 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.13 150.27 45.6 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.445 0.641 . . . . 100.0 110.497 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.78 167.12 20.32 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.637 -0.71 . . . . 100.0 110.223 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -93.89 7.76 43.79 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 113.919 1.081 . . . . 100.0 113.919 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.94 -18.87 57.28 Favored Glycine 0 C--N 1.356 1.653 0 N-CA-C 105.6 -3.0 . . . . 100.0 105.6 175.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.598 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 68.7 mm-40 -85.62 177.16 3.05 Favored Pre-proline 0 N--CA 1.437 -1.118 0 C-N-CA 130.113 3.365 . . . . 100.0 105.899 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.598 ' HD2' ' HB3' ' A' ' 6' ' ' GLU . 40.2 Cg_endo -56.77 153.1 38.55 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 123.173 2.582 . . . . 100.0 110.041 177.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.535 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 104' ' ' TRP . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.493 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.493 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.479 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.535 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 82' ' ' GLN . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.416 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.601 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.436 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.601 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.501 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.616 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.411 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.463 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttm . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 113.56 0.948 . . . . 100.0 113.56 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.5 86.7 6.5 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 106.764 -1.569 . . . . 100.0 106.764 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.18 -7.49 11.26 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.613 -0.721 . . . . 100.0 112.208 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -118.41 8.9 12.25 Favored 'General case' 0 C--N 1.362 1.144 0 N-CA-C 113.198 0.814 . . . . 100.0 113.198 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.39 -1.65 53.75 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 121.682 -0.636 . . . . 100.0 113.735 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -71.45 149.62 93.74 Favored Pre-proline 0 C--N 1.346 0.428 0 C-N-CA 125.421 1.488 . . . . 100.0 109.912 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.535 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 104' ' ' TRP . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.493 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.493 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.479 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.535 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 82' ' ' GLN . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.416 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.601 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.436 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.601 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.501 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.616 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.411 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.463 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.447 ' HB3' HG21 ' A' ' 9' ' ' VAL . 2.2 mmm . . . . . 0 CA--C 1.491 -1.289 0 N-CA-C 113.788 1.033 . . . . 100.0 113.788 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.32 -9.91 48.73 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 118.889 -0.577 . . . . 100.0 112.447 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -96.2 60.63 2.0 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 122.727 1.251 . . . . 100.0 109.486 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -139.01 12.11 2.64 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.531 -1.213 . . . . 100.0 110.412 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.98 -29.3 6.53 Favored Glycine 0 C--N 1.361 1.95 0 CA-C-N 119.515 1.052 . . . . 100.0 111.534 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -68.9 149.62 97.82 Favored Pre-proline 0 C--O 1.233 0.211 0 C-N-CA 130.51 3.524 . . . . 100.0 109.912 176.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 1' ' ' MET . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.535 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 104' ' ' TRP . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.493 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.493 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.437 HG12 ' HB2' ' A' ' 1' ' ' MET . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.479 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.535 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 82' ' ' GLN . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.416 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.601 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.436 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.601 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.501 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.616 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.411 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.463 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.441 ' O ' ' HB3' ' A' ' 56' ' ' ARG . 2.8 mtt . . . . . 0 N--CA 1.486 1.375 0 N-CA-C 108.047 -1.094 . . . . 100.0 108.047 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.17 80.87 1.66 Allowed 'General case' 0 CA--C 1.492 -1.287 1 N-CA-C 98.572 -4.603 . . . . 100.0 98.572 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.77 -5.82 59.0 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.835 -1.075 . . . . 100.0 112.17 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -90.85 84.95 5.87 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.136 -1.801 . . . . 100.0 106.136 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.38 -64.56 0.59 Allowed Glycine 0 C--N 1.35 1.341 0 N-CA-C 104.324 -3.51 . . . . 100.0 104.324 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.64 149.62 96.85 Favored Pre-proline 0 C--N 1.355 0.82 0 C-N-CA 123.243 0.617 . . . . 100.0 109.912 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.411 HG21 ' HB2' ' A' ' 1' ' ' MET . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.535 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 104' ' ' TRP . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.493 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.493 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.441 ' HB3' ' O ' ' A' ' 1' ' ' MET . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.479 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.535 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 82' ' ' GLN . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.416 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.601 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.436 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.601 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.501 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.616 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.411 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.463 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.496 -1.103 0 CA-C-O 120.277 0.084 . . . . 100.0 111.176 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.13 58.89 4.98 Favored 'General case' 0 C--N 1.361 1.078 0 CA-C-O 122.959 1.362 . . . . 100.0 111.324 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.1 -14.51 60.19 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 113.823 -1.535 . . . . 100.0 111.548 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -90.89 87.15 6.52 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 103.024 -2.954 . . . . 100.0 103.024 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.1 -87.94 0.25 Allowed Glycine 0 C--N 1.351 1.413 0 N-CA-C 105.881 -2.888 . . . . 100.0 105.881 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -75.01 149.62 85.32 Favored Pre-proline 0 C--N 1.357 0.906 0 CA-C-N 117.62 0.71 . . . . 100.0 109.912 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.535 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 104' ' ' TRP . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.493 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.493 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.479 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.535 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 82' ' ' GLN . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.416 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.601 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.436 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.601 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.501 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.616 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.413 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.411 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.463 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.234 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.11 149.62 87.37 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 174.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 0.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 0.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 0.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 0.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 0.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 0.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 0.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 0.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 0.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 0.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 0.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 0.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 0.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 0.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 0.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 0.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 0.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 0.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 0.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 0.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 0.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 0.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 0.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 0.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 0.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 0.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 0.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 0.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 0.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 0.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 0.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 0.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 0.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 0.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 0.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 0.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 0.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 0.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 0.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 0.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 0.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 0.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 0.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 0.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 0.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 0.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 0.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 0.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 0.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.319 0 N-CA-C 111.089 -0.804 . . . . 100.0 111.089 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -72.14 149.62 92.01 Favored Pre-proline 0 C--O 1.233 0.211 0 C-N-CA 128.209 2.603 . . . . 100.0 109.912 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.56 0 N-CA-C 115.127 0.811 . . . . 100.0 115.127 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -68.54 149.62 97.93 Favored Pre-proline 0 C--O 1.233 0.211 0 C-N-CA 126.143 1.777 . . . . 100.0 109.912 -176.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.253 0 CA-C-O 121.869 0.705 . . . . 100.0 113.412 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.29 149.62 86.94 Favored Pre-proline 0 C--N 1.331 -0.224 0 C-N-CA 131.329 3.852 . . . . 100.0 109.912 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.562 0 N-CA-C 106.709 -2.556 . . . . 100.0 106.709 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -83.63 149.62 57.72 Favored Pre-proline 0 C--N 1.351 0.639 0 C-N-CA 123.873 0.869 . . . . 100.0 109.912 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.936 0 N-CA-C 105.6 -3.0 . . . . 100.0 105.6 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.782 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 68.7 mm-40 -85.62 177.16 3.05 Favored Pre-proline 0 N--CA 1.437 -1.118 0 C-N-CA 130.113 3.365 . . . . 100.0 105.899 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.782 ' HD2' ' HB3' ' A' ' 6' ' ' GLU . 40.2 Cg_endo -56.77 153.1 38.55 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 123.173 2.582 . . . . 100.0 110.041 177.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.736 0 N-CA-C 113.735 0.254 . . . . 100.0 113.735 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -71.45 149.62 93.74 Favored Pre-proline 0 C--N 1.346 0.428 0 C-N-CA 125.421 1.488 . . . . 100.0 109.912 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.363 0 CA-C-O 122.491 1.05 . . . . 100.0 111.534 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -68.9 149.62 97.82 Favored Pre-proline 0 C--O 1.233 0.211 0 C-N-CA 130.51 3.524 . . . . 100.0 109.912 176.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.223 0 N-CA-C 104.324 -3.51 . . . . 100.0 104.324 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.64 149.62 96.85 Favored Pre-proline 0 C--N 1.355 0.82 0 C-N-CA 123.243 0.617 . . . . 100.0 109.912 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.365 0 N-CA-C 105.881 -2.888 . . . . 100.0 105.881 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -75.01 149.62 85.32 Favored Pre-proline 0 C--N 1.357 0.906 0 CA-C-N 117.62 0.71 . . . . 100.0 109.912 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.486 ' HG2' HG12 ' A' ' 169' ' ' ILE . 62.7 tpp . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.91 98.6 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.378 -0.231 . . . . 0.0 110.378 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.501 ' HB3' ' OE2' ' A' ' 6' ' ' GLU . . . -70.39 150.9 45.78 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 175.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -118.26 153.76 33.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.673 0.273 . . . . 0.0 111.14 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.45 -0.17 77.26 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -172.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.501 ' OE2' ' HB3' ' A' ' 3' ' ' ALA . 48.0 mt-10 -74.11 149.62 87.37 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 174.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 0.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 0.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 0.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 0.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 0.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 0.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 0.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 0.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 0.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 0.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 0.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 0.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 0.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 0.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 0.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 0.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 0.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 0.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 0.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 0.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 0.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 0.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 0.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 0.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 0.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 0.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 0.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 0.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 0.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 0.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 0.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 0.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 0.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 0.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 0.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 0.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 0.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 0.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 0.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 0.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 0.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 0.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 0.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 0.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 0.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 0.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 0.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 0.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 0.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.496 ' O ' HG21 ' A' ' 9' ' ' VAL . 3.4 mmt . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 113.671 0.989 . . . . 100.0 113.671 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.579 ' HB2' ' HD2' ' A' ' 56' ' ' ARG . . . -70.17 143.55 52.24 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 109.281 -0.637 . . . . 100.0 109.281 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.5 81.21 5.96 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-O 121.705 0.765 . . . . 100.0 109.003 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -121.27 84.46 2.24 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.072 0.949 . . . . 100.0 109.832 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.37 -28.42 9.01 Favored Glycine 0 C--N 1.355 1.637 0 N-CA-C 111.089 -0.804 . . . . 100.0 111.089 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -72.14 149.62 92.01 Favored Pre-proline 0 C--O 1.233 0.211 0 C-N-CA 128.209 2.603 . . . . 100.0 109.912 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 1' ' ' MET . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HA ' ' HB3' ' A' ' 56' ' ' ARG . 8.9 ttt . . . . . 0 CA--C 1.484 -1.589 0 N-CA-C 107.156 -1.424 . . . . 100.0 107.156 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 6' ' ' GLU . . . -122.11 80.21 1.68 Allowed 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 109.057 -0.72 . . . . 100.0 109.057 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.661 ' HB2' ' HD2' ' A' ' 58' ' ' PRO . . . -96.72 -10.06 27.66 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.974 -1.121 . . . . 100.0 107.974 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -97.92 110.96 23.43 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 105.102 -2.185 . . . . 100.0 105.102 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.98 -70.05 2.96 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 114.423 -1.262 . . . . 100.0 115.127 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.402 ' HB2' ' HB1' ' A' ' 2' ' ' ALA . 48.0 mt-10 -68.54 149.62 97.93 Favored Pre-proline 0 C--O 1.233 0.211 0 C-N-CA 126.143 1.777 . . . . 100.0 109.912 -176.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.661 ' HD2' ' HB2' ' A' ' 3' ' ' ALA . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.603 ' HB2' HG21 ' A' ' 9' ' ' VAL . 8.3 mtm . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 121.175 0.512 . . . . 100.0 111.206 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.27 -4.72 38.3 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 109.116 -0.698 . . . . 100.0 109.116 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -95.29 8.24 43.73 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 123.892 0.877 . . . . 100.0 109.864 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -97.07 -7.93 31.57 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 108.35 -0.982 . . . . 100.0 108.35 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.91 -12.47 45.54 Favored Glycine 0 C--N 1.365 2.146 0 CA-C-N 119.655 1.116 . . . . 100.0 113.412 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.29 149.62 86.94 Favored Pre-proline 0 C--N 1.331 -0.224 0 C-N-CA 131.329 3.852 . . . . 100.0 109.912 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.603 HG21 ' HB2' ' A' ' 1' ' ' MET . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.624 ' H1 ' ' HB3' ' A' ' 56' ' ' ARG . 3.7 mtm . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 121.869 0.842 . . . . 100.0 111.644 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.555 ' HB1' ' HA ' ' A' ' 8' ' ' GLN . . . -61.64 139.84 58.23 Favored 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 125.305 1.442 . . . . 100.0 111.681 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.15 21.91 12.71 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 114.646 1.35 . . . . 100.0 114.646 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -108.06 14.26 25.33 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 106.514 -1.661 . . . . 100.0 106.514 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.48 -40.53 1.58 Allowed Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 106.709 -2.556 . . . . 100.0 106.709 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -83.63 149.62 57.72 Favored Pre-proline 0 C--N 1.351 0.639 0 C-N-CA 123.873 0.869 . . . . 100.0 109.912 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.555 ' HA ' ' HB1' ' A' ' 2' ' ' ALA . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 1' ' ' MET . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.624 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mtt . . . . . 0 CA--C 1.498 -1.045 0 N-CA-C 105.492 -2.04 . . . . 100.0 105.492 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.13 150.27 45.6 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.445 0.641 . . . . 100.0 110.497 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.78 167.12 20.32 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.637 -0.71 . . . . 100.0 110.223 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -93.89 7.76 43.79 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 113.919 1.081 . . . . 100.0 113.919 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.94 -18.87 57.28 Favored Glycine 0 C--N 1.356 1.653 0 N-CA-C 105.6 -3.0 . . . . 100.0 105.6 175.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.782 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 68.7 mm-40 -85.62 177.16 3.05 Favored Pre-proline 0 N--CA 1.437 -1.118 0 C-N-CA 130.113 3.365 . . . . 100.0 105.899 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.782 ' HD2' ' HB3' ' A' ' 6' ' ' GLU . 40.2 Cg_endo -56.77 153.1 38.55 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 123.173 2.582 . . . . 100.0 110.041 177.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.554 ' HB3' HG21 ' A' ' 9' ' ' VAL . 1.6 ttm . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 113.56 0.948 . . . . 100.0 113.56 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.5 86.7 6.5 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 106.764 -1.569 . . . . 100.0 106.764 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.18 -7.49 11.26 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.613 -0.721 . . . . 100.0 112.208 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -118.41 8.9 12.25 Favored 'General case' 0 C--N 1.362 1.144 0 N-CA-C 113.198 0.814 . . . . 100.0 113.198 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.39 -1.65 53.75 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 121.682 -0.636 . . . . 100.0 113.735 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -71.45 149.62 93.74 Favored Pre-proline 0 C--N 1.346 0.428 0 C-N-CA 125.421 1.488 . . . . 100.0 109.912 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.554 HG21 ' HB3' ' A' ' 1' ' ' MET . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.528 HG12 ' HB2' ' A' ' 1' ' ' MET . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.652 ' HB2' HG12 ' A' ' 59' ' ' ILE . 2.2 mmm . . . . . 0 CA--C 1.491 -1.289 0 N-CA-C 113.788 1.033 . . . . 100.0 113.788 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.417 ' HB2' ' HG3' ' A' ' 8' ' ' GLN . . . -89.32 -9.91 48.73 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 118.889 -0.577 . . . . 100.0 112.447 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -96.2 60.63 2.0 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 122.727 1.251 . . . . 100.0 109.486 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -139.01 12.11 2.64 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.531 -1.213 . . . . 100.0 110.412 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.98 -29.3 6.53 Favored Glycine 0 C--N 1.361 1.95 0 CA-C-N 119.515 1.052 . . . . 100.0 111.534 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -68.9 149.62 97.82 Favored Pre-proline 0 C--O 1.233 0.211 0 C-N-CA 130.51 3.524 . . . . 100.0 109.912 176.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.417 ' HG3' ' HB2' ' A' ' 2' ' ' ALA . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.608 HG21 ' HB3' ' A' ' 1' ' ' MET . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.652 HG12 ' HB2' ' A' ' 1' ' ' MET . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.612 ' HB2' HG21 ' A' ' 9' ' ' VAL . 2.8 mtt . . . . . 0 N--CA 1.486 1.375 0 N-CA-C 108.047 -1.094 . . . . 100.0 108.047 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.461 ' H ' ' HB3' ' A' ' 1' ' ' MET . . . -120.17 80.87 1.66 Allowed 'General case' 0 CA--C 1.492 -1.287 1 N-CA-C 98.572 -4.603 . . . . 100.0 98.572 178.127 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.77 -5.82 59.0 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.835 -1.075 . . . . 100.0 112.17 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -90.85 84.95 5.87 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.136 -1.801 . . . . 100.0 106.136 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.38 -64.56 0.59 Allowed Glycine 0 C--N 1.35 1.341 0 N-CA-C 104.324 -3.51 . . . . 100.0 104.324 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.64 149.62 96.85 Favored Pre-proline 0 C--N 1.355 0.82 0 C-N-CA 123.243 0.617 . . . . 100.0 109.912 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.612 HG21 ' HB2' ' A' ' 1' ' ' MET . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.496 -1.103 0 CA-C-O 120.277 0.084 . . . . 100.0 111.176 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.13 58.89 4.98 Favored 'General case' 0 C--N 1.361 1.078 0 CA-C-O 122.959 1.362 . . . . 100.0 111.324 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.1 -14.51 60.19 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 113.823 -1.535 . . . . 100.0 111.548 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -90.89 87.15 6.52 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 103.024 -2.954 . . . . 100.0 103.024 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.1 -87.94 0.25 Allowed Glycine 0 C--N 1.351 1.413 0 N-CA-C 105.881 -2.888 . . . . 100.0 105.881 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -75.01 149.62 85.32 Favored Pre-proline 0 C--N 1.357 0.906 0 CA-C-N 117.62 0.71 . . . . 100.0 109.912 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.234 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.11 149.62 87.37 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 174.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 0.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 0.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 0.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 0.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 0.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 0.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 0.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 0.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 0.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 0.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 0.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 0.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 0.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 0.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 0.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 0.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 0.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 0.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 0.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 0.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 0.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 0.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 0.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 0.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 0.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 0.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 0.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 0.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 0.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 0.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 0.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 0.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 0.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 0.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 0.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.431 ' CD ' ' HB3' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 0.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 0.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 0.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 0.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 0.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 0.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 0.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 0.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 0.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 0.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 0.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 0.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 0.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 0.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.319 0 N-CA-C 111.089 -0.804 . . . . 100.0 111.089 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -72.14 149.62 92.01 Favored Pre-proline 0 C--O 1.233 0.211 0 C-N-CA 128.209 2.603 . . . . 100.0 109.912 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.431 ' CD ' ' HB3' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.56 0 N-CA-C 115.127 0.811 . . . . 100.0 115.127 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -68.54 149.62 97.93 Favored Pre-proline 0 C--O 1.233 0.211 0 C-N-CA 126.143 1.777 . . . . 100.0 109.912 -176.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.431 ' CD ' ' HB3' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.253 0 CA-C-O 121.869 0.705 . . . . 100.0 113.412 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.29 149.62 86.94 Favored Pre-proline 0 C--N 1.331 -0.224 0 C-N-CA 131.329 3.852 . . . . 100.0 109.912 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.431 ' CD ' ' HB3' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.562 0 N-CA-C 106.709 -2.556 . . . . 100.0 106.709 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -83.63 149.62 57.72 Favored Pre-proline 0 C--N 1.351 0.639 0 C-N-CA 123.873 0.869 . . . . 100.0 109.912 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.431 ' CD ' ' HB3' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.936 0 N-CA-C 105.6 -3.0 . . . . 100.0 105.6 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.782 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 68.7 mm-40 -85.62 177.16 3.05 Favored Pre-proline 0 N--CA 1.437 -1.118 0 C-N-CA 130.113 3.365 . . . . 100.0 105.899 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.782 ' HD2' ' HB3' ' A' ' 6' ' ' GLU . 40.2 Cg_endo -56.77 153.1 38.55 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 123.173 2.582 . . . . 100.0 110.041 177.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.431 ' CD ' ' HB3' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.736 0 N-CA-C 113.735 0.254 . . . . 100.0 113.735 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -71.45 149.62 93.74 Favored Pre-proline 0 C--N 1.346 0.428 0 C-N-CA 125.421 1.488 . . . . 100.0 109.912 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.431 ' CD ' ' HB3' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.363 0 CA-C-O 122.491 1.05 . . . . 100.0 111.534 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -68.9 149.62 97.82 Favored Pre-proline 0 C--O 1.233 0.211 0 C-N-CA 130.51 3.524 . . . . 100.0 109.912 176.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.431 ' CD ' ' HB3' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.223 0 N-CA-C 104.324 -3.51 . . . . 100.0 104.324 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.64 149.62 96.85 Favored Pre-proline 0 C--N 1.355 0.82 0 C-N-CA 123.243 0.617 . . . . 100.0 109.912 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.431 ' CD ' ' HB3' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.365 0 N-CA-C 105.881 -2.888 . . . . 100.0 105.881 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -75.01 149.62 85.32 Favored Pre-proline 0 C--N 1.357 0.906 0 CA-C-N 117.62 0.71 . . . . 100.0 109.912 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.431 ' CD ' ' HB3' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.486 ' HG2' HG12 ' A' ' 169' ' ' ILE . 62.7 tpp . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.91 98.6 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.378 -0.231 . . . . 0.0 110.378 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.501 ' HB3' ' OE2' ' A' ' 6' ' ' GLU . . . -70.39 150.9 45.78 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 175.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -118.26 153.76 33.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.673 0.273 . . . . 0.0 111.14 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.45 -0.17 77.26 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -172.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.501 ' OE2' ' HB3' ' A' ' 3' ' ' ALA . 48.0 mt-10 -74.11 149.62 87.37 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 174.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 0.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 0.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 0.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 0.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 0.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 0.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 0.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 0.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 0.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 0.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 0.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 0.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 0.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 0.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 0.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 0.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 0.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 0.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 0.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 0.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 0.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 0.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 0.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 0.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 0.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 0.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 0.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 0.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 0.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 0.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 0.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 0.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 0.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 0.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 0.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.431 ' CD ' ' HB3' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 0.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 0.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 0.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 0.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 0.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 0.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 0.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 0.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 0.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 0.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 0.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 0.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 0.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 0.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.496 ' O ' HG21 ' A' ' 9' ' ' VAL . 3.4 mmt . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 113.671 0.989 . . . . 100.0 113.671 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.579 ' HB2' ' HD2' ' A' ' 56' ' ' ARG . . . -70.17 143.55 52.24 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 109.281 -0.637 . . . . 100.0 109.281 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.5 81.21 5.96 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-O 121.705 0.765 . . . . 100.0 109.003 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -121.27 84.46 2.24 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.072 0.949 . . . . 100.0 109.832 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.37 -28.42 9.01 Favored Glycine 0 C--N 1.355 1.637 0 N-CA-C 111.089 -0.804 . . . . 100.0 111.089 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -72.14 149.62 92.01 Favored Pre-proline 0 C--O 1.233 0.211 0 C-N-CA 128.209 2.603 . . . . 100.0 109.912 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 1' ' ' MET . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.431 ' CD ' ' HB3' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HA ' ' HB3' ' A' ' 56' ' ' ARG . 8.9 ttt . . . . . 0 CA--C 1.484 -1.589 0 N-CA-C 107.156 -1.424 . . . . 100.0 107.156 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 6' ' ' GLU . . . -122.11 80.21 1.68 Allowed 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 109.057 -0.72 . . . . 100.0 109.057 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.661 ' HB2' ' HD2' ' A' ' 58' ' ' PRO . . . -96.72 -10.06 27.66 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.974 -1.121 . . . . 100.0 107.974 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -97.92 110.96 23.43 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 105.102 -2.185 . . . . 100.0 105.102 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.98 -70.05 2.96 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 114.423 -1.262 . . . . 100.0 115.127 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.402 ' HB2' ' HB1' ' A' ' 2' ' ' ALA . 48.0 mt-10 -68.54 149.62 97.93 Favored Pre-proline 0 C--O 1.233 0.211 0 C-N-CA 126.143 1.777 . . . . 100.0 109.912 -176.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.661 ' HD2' ' HB2' ' A' ' 3' ' ' ALA . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.431 ' CD ' ' HB3' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.603 ' HB2' HG21 ' A' ' 9' ' ' VAL . 8.3 mtm . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 121.175 0.512 . . . . 100.0 111.206 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.27 -4.72 38.3 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 109.116 -0.698 . . . . 100.0 109.116 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -95.29 8.24 43.73 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 123.892 0.877 . . . . 100.0 109.864 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -97.07 -7.93 31.57 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 108.35 -0.982 . . . . 100.0 108.35 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.91 -12.47 45.54 Favored Glycine 0 C--N 1.365 2.146 0 CA-C-N 119.655 1.116 . . . . 100.0 113.412 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.29 149.62 86.94 Favored Pre-proline 0 C--N 1.331 -0.224 0 C-N-CA 131.329 3.852 . . . . 100.0 109.912 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.603 HG21 ' HB2' ' A' ' 1' ' ' MET . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.431 ' CD ' ' HB3' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.624 ' H1 ' ' HB3' ' A' ' 56' ' ' ARG . 3.7 mtm . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 121.869 0.842 . . . . 100.0 111.644 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.555 ' HB1' ' HA ' ' A' ' 8' ' ' GLN . . . -61.64 139.84 58.23 Favored 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 125.305 1.442 . . . . 100.0 111.681 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.15 21.91 12.71 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 114.646 1.35 . . . . 100.0 114.646 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -108.06 14.26 25.33 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 106.514 -1.661 . . . . 100.0 106.514 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.48 -40.53 1.58 Allowed Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 106.709 -2.556 . . . . 100.0 106.709 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -83.63 149.62 57.72 Favored Pre-proline 0 C--N 1.351 0.639 0 C-N-CA 123.873 0.869 . . . . 100.0 109.912 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.555 ' HA ' ' HB1' ' A' ' 2' ' ' ALA . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 1' ' ' MET . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.624 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.431 ' CD ' ' HB3' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mtt . . . . . 0 CA--C 1.498 -1.045 0 N-CA-C 105.492 -2.04 . . . . 100.0 105.492 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.13 150.27 45.6 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.445 0.641 . . . . 100.0 110.497 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.78 167.12 20.32 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.637 -0.71 . . . . 100.0 110.223 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -93.89 7.76 43.79 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 113.919 1.081 . . . . 100.0 113.919 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.94 -18.87 57.28 Favored Glycine 0 C--N 1.356 1.653 0 N-CA-C 105.6 -3.0 . . . . 100.0 105.6 175.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.782 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 68.7 mm-40 -85.62 177.16 3.05 Favored Pre-proline 0 N--CA 1.437 -1.118 0 C-N-CA 130.113 3.365 . . . . 100.0 105.899 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.782 ' HD2' ' HB3' ' A' ' 6' ' ' GLU . 40.2 Cg_endo -56.77 153.1 38.55 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 123.173 2.582 . . . . 100.0 110.041 177.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.431 ' CD ' ' HB3' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.554 ' HB3' HG21 ' A' ' 9' ' ' VAL . 1.6 ttm . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 113.56 0.948 . . . . 100.0 113.56 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.5 86.7 6.5 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 106.764 -1.569 . . . . 100.0 106.764 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.18 -7.49 11.26 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.613 -0.721 . . . . 100.0 112.208 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -118.41 8.9 12.25 Favored 'General case' 0 C--N 1.362 1.144 0 N-CA-C 113.198 0.814 . . . . 100.0 113.198 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.39 -1.65 53.75 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 121.682 -0.636 . . . . 100.0 113.735 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -71.45 149.62 93.74 Favored Pre-proline 0 C--N 1.346 0.428 0 C-N-CA 125.421 1.488 . . . . 100.0 109.912 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.554 HG21 ' HB3' ' A' ' 1' ' ' MET . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.528 HG12 ' HB2' ' A' ' 1' ' ' MET . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.431 ' CD ' ' HB3' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.652 ' HB2' HG12 ' A' ' 59' ' ' ILE . 2.2 mmm . . . . . 0 CA--C 1.491 -1.289 0 N-CA-C 113.788 1.033 . . . . 100.0 113.788 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.417 ' HB2' ' HG3' ' A' ' 8' ' ' GLN . . . -89.32 -9.91 48.73 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 118.889 -0.577 . . . . 100.0 112.447 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -96.2 60.63 2.0 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 122.727 1.251 . . . . 100.0 109.486 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -139.01 12.11 2.64 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.531 -1.213 . . . . 100.0 110.412 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.98 -29.3 6.53 Favored Glycine 0 C--N 1.361 1.95 0 CA-C-N 119.515 1.052 . . . . 100.0 111.534 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -68.9 149.62 97.82 Favored Pre-proline 0 C--O 1.233 0.211 0 C-N-CA 130.51 3.524 . . . . 100.0 109.912 176.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.417 ' HG3' ' HB2' ' A' ' 2' ' ' ALA . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.608 HG21 ' HB3' ' A' ' 1' ' ' MET . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.652 HG12 ' HB2' ' A' ' 1' ' ' MET . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.431 ' CD ' ' HB3' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.612 ' HB2' HG21 ' A' ' 9' ' ' VAL . 2.8 mtt . . . . . 0 N--CA 1.486 1.375 0 N-CA-C 108.047 -1.094 . . . . 100.0 108.047 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.461 ' H ' ' HB3' ' A' ' 1' ' ' MET . . . -120.17 80.87 1.66 Allowed 'General case' 0 CA--C 1.492 -1.287 1 N-CA-C 98.572 -4.603 . . . . 100.0 98.572 178.127 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.77 -5.82 59.0 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.835 -1.075 . . . . 100.0 112.17 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -90.85 84.95 5.87 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.136 -1.801 . . . . 100.0 106.136 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.38 -64.56 0.59 Allowed Glycine 0 C--N 1.35 1.341 0 N-CA-C 104.324 -3.51 . . . . 100.0 104.324 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.64 149.62 96.85 Favored Pre-proline 0 C--N 1.355 0.82 0 C-N-CA 123.243 0.617 . . . . 100.0 109.912 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.612 HG21 ' HB2' ' A' ' 1' ' ' MET . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.431 ' CD ' ' HB3' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.496 -1.103 0 CA-C-O 120.277 0.084 . . . . 100.0 111.176 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.13 58.89 4.98 Favored 'General case' 0 C--N 1.361 1.078 0 CA-C-O 122.959 1.362 . . . . 100.0 111.324 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.1 -14.51 60.19 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 113.823 -1.535 . . . . 100.0 111.548 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -90.89 87.15 6.52 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 103.024 -2.954 . . . . 100.0 103.024 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.1 -87.94 0.25 Allowed Glycine 0 C--N 1.351 1.413 0 N-CA-C 105.881 -2.888 . . . . 100.0 105.881 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -75.01 149.62 85.32 Favored Pre-proline 0 C--N 1.357 0.906 0 CA-C-N 117.62 0.71 . . . . 100.0 109.912 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.22 153.1 72.18 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 120.775 0.983 . . . . 100.0 110.041 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -50.56 134.64 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.157 -0.617 . . . . 100.0 110.17 -174.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.17 123.73 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.48 . . . . 100.0 109.976 -173.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 57.1 mt-30 -111.72 132.02 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.645 -0.707 . . . . 100.0 110.674 177.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 94.6 m-85 -114.82 128.43 56.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.065 -0.346 . . . . 100.0 110.065 173.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -73.78 113.29 10.76 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.548 -0.461 . . . . 100.0 109.828 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 63' ' ' VAL . 42.1 tp -103.06 125.61 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.18 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG13 ' CE2' ' A' ' 79' ' ' TYR . 39.4 t -104.81 120.73 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.697 -0.683 . . . . 100.0 109.448 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 80.7 mt -104.93 125.44 50.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 100.0 109.908 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HG12 ' A' ' 88' ' ' ILE . 50.5 t -126.87 140.82 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 100.0 110.572 -174.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.02 44.39 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.966 -0.561 . . . . 100.0 112.099 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 164.88 11.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.203 0.502 . . . . 100.0 110.846 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.43 138.81 41.04 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 119.953 -1.118 . . . . 100.0 110.782 172.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 2.76 73.33 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.774 -0.727 . . . . 100.0 113.794 -175.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.0 p -77.39 -25.0 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.529 0.664 . . . . 100.0 111.1 172.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.29 69.91 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.755 -0.736 . . . . 100.0 112.424 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 27.8 ttpp -58.27 -44.18 88.3 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.622 -0.34 . . . . 100.0 111.004 -175.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 m -64.02 -38.36 90.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.589 -0.278 . . . . 100.0 110.916 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.4 m -58.79 -38.47 78.6 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 100.0 109.484 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HE1' ' HA ' ' A' ' 157' ' ' PHE . 2.4 t80 -57.03 -44.99 83.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.195 -1.039 . . . . 100.0 108.195 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.69 -41.34 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.347 -0.612 . . . . 100.0 109.347 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -58.37 -29.54 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 100.0 110.363 -175.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.405 HH22 ' HG3' ' A' ' 186' ' ' GLU . 87.1 mmt-85 -59.34 -35.61 74.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.816 0.302 . . . . 100.0 111.816 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.607 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 50.6 t-80 -82.65 108.12 15.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.632 -0.427 . . . . 100.0 110.694 -174.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 tp -60.01 -44.48 94.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.35 -0.386 . . . . 100.0 111.693 -172.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.607 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 88.8 m -60.49 -40.75 92.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.023 -0.362 . . . . 100.0 110.023 -177.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.22 -36.6 91.17 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.666 -0.778 . . . . 100.0 112.353 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.43 -46.64 72.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 100.0 110.331 174.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -63.84 -41.95 97.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 100.0 110.722 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -95.27 18.03 13.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.324 -0.398 . . . . 100.0 111.618 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -52.09 130.41 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 100.0 111.402 -175.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 67.7 mttm -126.43 159.57 32.95 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.289 -0.634 . . . . 100.0 109.289 174.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -129.43 139.98 51.47 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.099 -0.375 . . . . 100.0 111.357 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 43' ' ' LEU . 96.8 t -109.75 113.42 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.183 -0.673 . . . . 100.0 109.183 174.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.62 81.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 100.0 110.736 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -55.74 -48.95 74.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.645 0.26 . . . . 100.0 110.454 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 40' ' ' VAL . 99.7 mt -77.52 -29.15 52.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 100.0 111.921 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.43 27.38 57.56 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.967 -0.853 . . . . 100.0 110.967 -172.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.7 t -122.63 135.84 61.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.885 0.374 . . . . 100.0 111.467 -171.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -75.17 144.04 42.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 100.0 110.863 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 38' ' ' LYS . 60.0 t -112.37 123.58 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.096 -0.705 . . . . 100.0 109.096 175.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -125.38 102.38 30.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.678 -0.237 . . . . 100.0 111.567 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 36.8 Cg_exo -68.39 119.82 6.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 120.85 1.033 . . . . 100.0 110.329 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' CG ' ' A' ' 30' ' ' HIS . 30.5 mt -113.22 114.88 27.36 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.506 -0.478 . . . . 100.0 110.416 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.0 128.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.148 -0.686 . . . . 100.0 109.148 -175.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.54 132.86 54.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 100.0 110.476 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 178' ' ' ALA . 90.5 m-70 -91.79 110.77 22.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.46 -0.336 . . . . 100.0 110.568 -173.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 174' ' ' LEU . 18.9 p -110.92 172.75 6.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.52 . . . . 100.0 110.503 -173.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.34 -38.92 74.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.437 -0.347 . . . . 100.0 110.946 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.621 ' HG3' HD13 ' A' ' 169' ' ' ILE . 37.0 mmt180 -66.22 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 100.0 110.17 175.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.14 -178.34 20.86 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.647 -0.581 . . . . 100.0 111.647 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.47 128.36 20.06 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 121.273 1.315 . . . . 100.0 111.015 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.518 HD12 HG21 ' A' ' 54' ' ' THR . 92.5 mt -116.09 121.87 68.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.028 -0.73 . . . . 100.0 109.028 175.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.562 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 40.6 ttmt -90.92 123.28 34.3 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.837 -0.345 . . . . 100.0 110.7 177.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' A' ' 165' ' ' ALA . 96.8 m-85 -101.94 109.56 21.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.157 -0.683 . . . . 100.0 109.157 173.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -79.53 91.65 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.433 -0.58 . . . . 100.0 109.433 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG22 HD23 ' A' ' 13' ' ' LEU . 54.8 t -77.34 127.83 38.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.675 -0.693 . . . . 100.0 110.9 -173.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -100.74 118.81 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.473 -0.785 . . . . 100.0 109.756 175.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -116.71 115.34 25.45 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 100.0 111.045 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.568 HG21 HD22 ' A' ' 75' ' ' LEU . 67.5 p -63.43 137.12 58.04 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.959 -0.386 . . . . 100.0 109.959 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.85 69.02 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.735 -0.386 . . . . 100.0 111.263 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.15 0.36 89.55 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.572 -0.347 . . . . 100.0 113.437 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.06 -35.71 77.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.457 -0.437 . . . . 100.0 111.044 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -59.7 -41.36 90.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.624 -0.262 . . . . 100.0 110.401 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.86 -36.15 82.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.317 -0.253 . . . . 100.0 110.317 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -63.94 -39.22 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.571 -0.286 . . . . 100.0 110.607 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.79 -144.46 11.3 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.767 -0.73 . . . . 100.0 113.043 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.07 160.91 38.07 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.179 -0.534 . . . . 100.0 112.409 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 66' ' ' THR . 82.7 mt -101.35 141.03 34.82 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.643 -0.328 . . . . 100.0 111.19 -173.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.14 145.8 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 100.0 110.886 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -54.72 -34.43 62.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 100.0 111.035 -174.521 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HD12 ' A' ' 81' ' ' ILE . . . -53.96 -40.75 66.4 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.616 -0.802 . . . . 100.0 112.178 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.634 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.8 t80 -59.52 -43.4 93.43 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.48 -0.424 . . . . 100.0 110.979 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 75' ' ' LEU . 70.8 m-85 -72.62 -29.42 63.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.359 . . . . 100.0 111.015 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.599 HD12 ' HA2' ' A' ' 78' ' ' GLY . 80.9 mt -57.35 135.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.976 0.417 . . . . 100.0 110.823 -172.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.589 ' HG3' HG22 ' A' ' 81' ' ' ILE . 85.1 mt-30 63.53 35.18 12.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 100.0 111.958 -177.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.02 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.986 -0.285 . . . . 100.0 110.247 173.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -57.41 -34.58 69.05 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 11' ' ' PHE . 24.1 m -132.72 151.88 51.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.831 -0.622 . . . . 100.0 109.966 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -138.89 135.27 34.29 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.261 0.467 . . . . 100.0 112.261 177.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.81 HG12 ' HB ' ' A' ' 118' ' ' VAL . 78.2 mt -130.03 124.17 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.025 -0.731 . . . . 100.0 109.025 172.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.624 HG12 ' HB ' ' A' ' 16' ' ' VAL . 89.1 mt -113.31 131.52 64.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.597 -0.52 . . . . 100.0 109.597 177.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 58.2 mtt -120.38 142.02 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 100.0 110.888 -173.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 47.1 p90 -125.98 144.54 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.837 -0.345 . . . . 100.0 111.44 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 94' ' ' SER . 21.8 t0 -71.32 120.44 16.91 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.609 -0.515 . . . . 100.0 109.609 174.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.717 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 34.6 m -60.65 -36.01 67.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 110.338 -0.245 . . . . 100.0 110.338 -174.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.3 p -70.65 -36.06 73.2 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.01 -0.276 . . . . 100.0 110.881 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 91' ' ' ASP . 31.2 t -87.57 106.07 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.85 0.685 . . . . 100.0 112.85 -173.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.57 -36.29 83.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 100.0 110.153 174.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.37 -44.23 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.958 -0.756 . . . . 100.0 108.958 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.462 HG21 ' H ' ' A' ' 91' ' ' ASP . 87.0 m -64.85 -39.48 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.42 -0.512 . . . . 100.0 110.228 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.86 -41.8 92.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.059 -0.349 . . . . 100.0 110.059 175.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.2 mttt -63.81 -30.73 71.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.968 0.413 . . . . 100.0 110.402 178.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.545 ' HA ' HD22 ' A' ' 103' ' ' ASN . 96.5 m-20 -73.96 -24.16 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 100.0 111.933 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 102' ' ' PRO . 53.3 t -55.62 -51.01 83.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 120.899 -0.32 . . . . 100.0 110.175 -174.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 101' ' ' VAL . 93.9 Cg_exo -53.86 -37.35 85.15 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 120.792 0.995 . . . . 100.0 111.663 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 100' ' ' ASN . 70.0 m-80 -66.96 -46.29 75.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 100.0 110.135 -177.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.61 ' HB3' HG11 ' A' ' 16' ' ' VAL . 90.8 m95 -62.53 -42.52 99.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.639 -0.504 . . . . 100.0 109.639 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -57.25 -43.35 82.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 100.0 110.114 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 -61.03 -46.75 89.47 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.321 -0.252 . . . . 100.0 110.321 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.64 -43.69 98.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.345 . . . . 100.0 110.146 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 86' ' ' ALA . 64.1 tp -59.57 -48.47 81.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 100.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.48 -37.83 81.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.387 -0.597 . . . . 100.0 109.387 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -58.97 -42.97 91.19 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.465 -0.494 . . . . 100.0 109.967 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 67.4 t -78.5 -48.88 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.973 -0.291 . . . . 100.0 110.885 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 82.2 m -127.7 141.59 51.56 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.048 0.388 . . . . 100.0 112.048 -174.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -130.33 157.38 42.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.383 . . . . 100.0 111.378 -175.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.5 t30 62.08 38.95 13.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.643 0.258 . . . . 100.0 111.22 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 115' ' ' ILE . 47.9 pt -121.58 133.3 24.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.622 -0.51 . . . . 100.0 109.622 -178.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.17 132.53 42.02 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 120.457 0.772 . . . . 100.0 111.565 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.24 128.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.401 -0.592 . . . . 100.0 109.401 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.81 ' HB ' HG12 ' A' ' 87' ' ' ILE . 56.9 t -111.68 117.83 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 100.0 108.738 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.1 mt -105.01 121.27 43.42 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.839 -0.345 . . . . 100.0 110.487 -176.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 147' ' ' TYR . 72.9 m -129.2 141.16 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.841 0.682 . . . . 100.0 112.841 -173.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.14 128.0 9.35 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.237 -1.145 . . . . 100.0 110.237 171.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 24.6 t-20 -113.3 158.53 20.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.239 0.52 . . . . 100.0 111.867 -172.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 56.2 mtpt 74.7 27.21 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.516 . . . . 100.0 111.967 174.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.846 HG12 ' HB2' ' A' ' 150' ' ' SER . 9.4 p -59.89 -16.32 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.352 -0.61 . . . . 100.0 109.352 176.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 126' ' ' ILE . 1.6 p30 -49.01 -32.23 8.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 100.0 111.013 175.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG13 ' OD1' ' A' ' 125' ' ' ASP . 92.5 mt -76.93 124.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 100.0 109.634 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HE3' HD11 ' A' ' 193' ' ' LEU . 63.5 mttp -61.02 -34.33 74.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 100.0 111.085 -176.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -78.1 72.78 4.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 100.0 110.554 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 76.1 ttt180 -82.94 95.72 8.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 100.0 110.306 176.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.02 -37.06 75.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.548 -0.296 . . . . 100.0 111.603 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.82 115.84 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.208 -0.664 . . . . 100.0 109.208 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -119.15 170.22 9.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 100.0 110.892 -173.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.11 -40.77 59.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.226 -0.189 . . . . 100.0 110.893 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.91 -41.38 97.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.484 0.183 . . . . 100.0 110.924 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.8 p -74.73 -20.24 59.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.768 0.318 . . . . 100.0 111.574 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.406 HG23 ' ND1' ' A' ' 139' ' ' HIS . 96.2 mt -78.95 99.34 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.926 -0.768 . . . . 100.0 108.926 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.73 -30.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 100.0 110.209 -176.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -53.61 -39.93 65.32 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.742 -0.466 . . . . 100.0 109.742 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.406 ' ND1' HG23 ' A' ' 136' ' ' ILE . 61.7 m80 -59.05 -48.1 82.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.6 -0.727 . . . . 100.0 109.978 -176.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -62.89 -41.45 99.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.905 -0.405 . . . . 100.0 109.905 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -63.01 -36.08 82.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 100.0 110.32 -174.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -92.33 -1.7 56.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 100.0 111.529 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.1 t30 60.26 35.33 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.681 0.277 . . . . 100.0 110.687 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.4 mt -109.88 134.02 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.404 . . . . 100.0 110.546 176.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -67.69 142.25 56.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 100.0 111.691 -174.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -92.65 140.64 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 100.0 111.108 174.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.872 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 56.9 m-85 -130.7 137.69 49.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 100.0 110.402 176.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -102.5 111.26 23.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.836 -0.165 . . . . 100.0 110.977 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 42.8 pt -130.21 148.78 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.089 -0.337 . . . . 100.0 110.089 -175.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.846 ' HB2' HG12 ' A' ' 124' ' ' VAL . 38.3 t -133.53 99.37 4.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.344 -0.542 . . . . 100.0 110.967 173.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.61 89.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 100.0 111.356 -173.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.576 ' HG2' HG22 ' A' ' 187' ' ' VAL . 89.0 tttt -58.55 -35.85 72.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 100.0 110.314 -176.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 187' ' ' VAL . 95.4 p -96.82 -4.56 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 100.0 111.391 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.4 t30 61.97 31.64 18.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 100.0 110.316 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 85.4 t80 -78.41 126.1 30.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.414 -0.357 . . . . 100.0 110.956 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 62.03 35.94 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.966 -0.561 . . . . 100.0 111.835 175.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' HA ' ' HE1' ' A' ' 26' ' ' PHE . 92.4 t80 -57.68 -47.09 83.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.006 0.432 . . . . 100.0 110.67 -176.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -74.03 -26.14 60.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.742 -0.663 . . . . 100.0 112.688 -173.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.741 ' HE2' ' HD2' ' A' ' 147' ' ' TYR . 88.0 tttt -53.38 -57.21 17.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.546 0.943 . . . . 100.0 113.546 -170.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.431 ' CD ' ' HB3' ' A' ' 159' ' ' LYS . 29.7 Cg_endo -57.81 -40.01 82.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 120.797 0.998 . . . . 100.0 112.166 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -67.39 -46.13 74.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.778 -0.453 . . . . 100.0 109.778 -177.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.7 -47.74 82.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 100.0 110.38 -176.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.34 -41.77 98.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 100.0 111.145 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 85' ' ' CYS . 64.7 tp -58.65 -46.32 87.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.618 -0.512 . . . . 100.0 109.618 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HB2' ' HZ ' ' A' ' 61' ' ' PHE . . . -62.79 -41.39 99.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 110.174 -0.306 . . . . 100.0 110.174 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 99.5 mtt180 -60.51 -40.11 90.24 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.249 -0.278 . . . . 100.0 110.249 178.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.49 -47.96 79.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.658 -0.497 . . . . 100.0 109.658 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 85' ' ' CYS . 64.1 mt -62.5 -49.32 75.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 100.0 110.342 -173.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 174' ' ' LEU . 96.7 mt -72.3 -33.23 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 100.0 110.005 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 87.53 13.29 65.57 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.841 -0.695 . . . . 100.0 111.416 -172.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -103.95 99.82 18.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 122.3 0.24 . . . . 100.0 111.112 -174.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.53 -25.69 70.01 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 121.712 1.608 . . . . 100.0 112.391 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -93.11 8.69 39.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 100.0 111.405 -173.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 HD12 ' A' ' 169' ' ' ILE . 47.6 tp -64.59 137.09 57.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.793 -0.363 . . . . 100.0 110.957 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -133.39 145.55 50.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 100.0 111.001 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 54' ' ' THR . 9.2 m-30 -77.3 100.75 6.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.443 -0.576 . . . . 100.0 109.443 173.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.24 -40.8 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 100.0 109.779 -176.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . . . -131.15 146.37 52.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.955 -0.298 . . . . 100.0 111.18 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.2 ttp -104.83 126.1 32.08 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.61 -0.268 . . . . 100.0 111.217 -175.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.44 153.86 76.32 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 121.213 1.276 . . . . 100.0 111.556 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.44 131.02 48.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.655 -0.418 . . . . 100.0 110.651 -176.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.83 138.49 54.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.445 -0.343 . . . . 100.0 111.114 -176.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 148.85 96.03 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 120.562 0.22 . . . . 100.0 110.448 175.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 43.1 Cg_endo -60.08 141.41 96.16 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 121.292 1.328 . . . . 100.0 113.115 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 37.2 Cg_exo -66.16 148.32 84.93 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.077 1.851 . . . . 100.0 112.339 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.405 ' HG3' HH22 ' A' ' 29' ' ' ARG . 61.0 mt-10 -66.87 -41.71 86.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.647 0.26 . . . . 100.0 110.71 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' A' ' 152' ' ' LYS . 35.4 m -132.32 162.96 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 174.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.94 125.63 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.159 -0.682 . . . . 100.0 109.159 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.6 tpp -64.57 134.72 54.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.94 -0.304 . . . . 100.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 192' ' ' ALA . 34.6 t70 -68.77 121.03 79.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.739 -0.467 . . . . 100.0 109.739 174.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -54.76 -41.26 79.7 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.471 1.448 . . . . 100.0 112.118 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.452 ' HB3' ' OD2' ' A' ' 190' ' ' ASP . . . -62.8 -46.05 89.8 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 100.0 110.164 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.431 HD11 ' HE3' ' A' ' 127' ' ' LYS . 81.4 mt -61.51 -45.79 92.7 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.71 -0.396 . . . . 100.0 109.957 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.89 96.16 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.709 -0.478 . . . . 100.0 109.709 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.29 -43.03 99.54 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.993 -0.373 . . . . 100.0 109.993 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -61.08 -44.81 96.8 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.488 -0.56 . . . . 100.0 109.488 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -60.9 -47.36 86.74 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.035 -0.728 . . . . 100.0 109.035 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.79 -43.41 96.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.717 -0.674 . . . . 100.0 110.217 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.72 -43.54 98.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 100.0 110.059 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.674 -0.491 . . . . 100.0 109.674 -178.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.83 -43.11 99.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.821 -0.437 . . . . 100.0 109.821 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.68 -43.16 99.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.505 -0.316 . . . . 100.0 110.236 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.33 -43.12 98.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.104 -0.702 . . . . 100.0 109.104 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.75 -43.08 98.42 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 100.0 109.992 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -63.26 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.016 -0.364 . . . . 100.0 110.016 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.2 m -69.87 -28.31 65.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 100.0 110.71 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.9 m -57.15 135.39 56.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 100.0 110.881 -173.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.13 62.55 6.67 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.573 0.582 . . . . 100.0 112.573 -172.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 82.4 mt -124.02 146.06 49.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.953 -0.388 . . . . 100.0 109.953 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -55.04 -28.92 62.54 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 120.947 1.098 . . . . 100.0 112.207 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.44 173.82 11.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.595 -0.275 . . . . 100.0 110.279 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -57.88 -35.57 71.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 100.0 110.197 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.44 146.47 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 100.0 110.114 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.1 59.87 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.444 -0.576 . . . . 100.0 109.444 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.69 -30.02 70.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 100.0 110.739 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.832 -1.08 . . . . 100.0 111.29 -176.315 . . . . . . . . 0 0 . 1 stop_ save_